1 Min Read
Nov 20 (Reuters) - Cadila Healthcare Ltd:
* WHO INN committee grants name Desidustat to Zydus Cadila’s phase II anemia candidate, Zyan1
Source text - bit.ly/2jHhZi5
Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.